ADAM PROTEIN;
GELATINASE B;
INTERSTITIAL COLLAGENASE;
LOW DENSITY LIPOPROTEIN;
MATRIX METALLOPROTEINASE;
MESSENGER RNA;
METALLOPROTEINASE;
METFORMIN;
OXIDIZED LOW DENSITY LIPOPROTEIN;
PROTEIN ADAM 15;
PROTEIN ADAM 28;
PROTEIN ADAM 8;
SULFONYLUREA;
TISSUE INHIBITOR OF METALLOPROTEINASE;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;
UNCLASSIFIED DRUG;
TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;
ADULT;
AGED;
ARTICLE;
ATHEROSCLEROTIC PLAQUE;
CELL ADHESION;
CELL LINE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DIABETIC DIET;
FEMALE;
GENE EXPRESSION;
HUMAN;
HUMAN CELL;
LIPOPROTEIN BLOOD LEVEL;
MALE;
MONOCYTE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
REAL TIME POLYMERASE CHAIN REACTION;
BLOOD;
CAUCASIAN;
DRUG EFFECT;
ENZYMOLOGY;
GENE EXPRESSION REGULATION;
GENETICS;
ISOLATION AND PURIFICATION;
MIDDLE AGED;
POLYMERASE CHAIN REACTION;
REFERENCE VALUE;
TUMOR CELL LINE;
Dual role of the matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture
10.1152/physrev.00048.2003 15618476
Newby AC: Dual role of the matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005, 85:1-31. 10.1152/physrev.00048.2003 15618476
LDL oxidative modifications in well- or moderately controlled type 2 diabetes
10.1002/dmrr.461 15250032
Scheffer PG Henry RM Wever EJ van Rooij GJ Bos G Heine RJ Dekker JM Diamant M Stehouwer CD Nijpels G Blankenstein MA Teerlink T: LDL oxidative modifications in well- or moderately controlled type 2 diabetes. Diabetes Metab Res Rev 2004, 20:298-304. 10.1002/dmrr.461 15250032
ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranes
10.1089/108729001750171353 11334139
Condon TP Flournoy S Sawyer GJ Baker BF Kishimoto TK Bennett CF: ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranes. Antisense Nucleic Acid Drug Dev 2001, 11:107-116. 10.1089/108729001750171353 11334139
Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: Protection by nitric oxide donor
10.1053/meta.2003.50049 12647268
Sonoki K Iwase M Iino K Ichikawa K Ohdo S Higuchi S Yoshinari M Iida M: Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: Protection by nitric oxide donor. Metabolism 2003, 52:308-314. 10.1053/meta.2003.50049 12647268
Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidised plasma low density lipoprotein in type II diabetes
10.1042/CS20050089 15853770
Sampson MJ Braschi S Willis G Astley SB: Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidised plasma low density lipoprotein in type II diabetes. Clin Sci 2005, 109:189-192. 10.1042/CS20050089 15853770
